KR102481455B1 - 헬리코박터 치료제 - Google Patents

헬리코박터 치료제 Download PDF

Info

Publication number
KR102481455B1
KR102481455B1 KR1020177002217A KR20177002217A KR102481455B1 KR 102481455 B1 KR102481455 B1 KR 102481455B1 KR 1020177002217 A KR1020177002217 A KR 1020177002217A KR 20177002217 A KR20177002217 A KR 20177002217A KR 102481455 B1 KR102481455 B1 KR 102481455B1
Authority
KR
South Korea
Prior art keywords
gly
ile
lys
asn
val
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
KR1020177002217A
Other languages
English (en)
Korean (ko)
Other versions
KR20170016989A (ko
Inventor
필립 수톤
Original Assignee
머독 칠드런스 리서치 인스티튜트
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2014902493A external-priority patent/AU2014902493A0/en
Application filed by 머독 칠드런스 리서치 인스티튜트 filed Critical 머독 칠드런스 리서치 인스티튜트
Publication of KR20170016989A publication Critical patent/KR20170016989A/ko
Application granted granted Critical
Publication of KR102481455B1 publication Critical patent/KR102481455B1/ko
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/482—Serine endopeptidases (3.4.21)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/105—Delta proteobacteriales, e.g. Lawsonia; Epsilon proteobacteriales, e.g. campylobacter, helicobacter
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1203—Gram-negative bacteria
    • C07K16/121—Helicobacter (G); Campylobacter (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/73—Inducing cell death, e.g. apoptosis, necrosis or inhibition of cell proliferation
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/76—Antagonist effect on antigen, e.g. neutralization or inhibition of binding
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
    • Y10S514/925—
    • Y10S514/926—

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
KR1020177002217A 2014-06-30 2015-06-30 헬리코박터 치료제 Active KR102481455B1 (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AU2014902493A AU2014902493A0 (en) 2014-06-30 Helicobacter therapeutic
AU2014902493 2014-06-30
PCT/AU2015/000380 WO2016000022A1 (en) 2014-06-30 2015-06-30 Helicobacter therapeutic

Publications (2)

Publication Number Publication Date
KR20170016989A KR20170016989A (ko) 2017-02-14
KR102481455B1 true KR102481455B1 (ko) 2022-12-26

Family

ID=55018143

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020177002217A Active KR102481455B1 (ko) 2014-06-30 2015-06-30 헬리코박터 치료제

Country Status (9)

Country Link
US (3) US20170165347A1 (enExample)
EP (1) EP3160492A4 (enExample)
JP (1) JP6634444B2 (enExample)
KR (1) KR102481455B1 (enExample)
CN (2) CN113694191A (enExample)
AU (1) AU2015283805B2 (enExample)
BR (1) BR112016030728A2 (enExample)
RU (1) RU2017100658A (enExample)
WO (1) WO2016000022A1 (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101885460B1 (ko) 2017-02-07 2018-08-03 두산중공업 주식회사 가스터빈용 프리 스월러 장치
CN108531468B (zh) * 2018-02-24 2020-07-17 广东工业大学 编码重组幽门螺杆菌丝氨酸蛋白酶的基因、卵黄抗体与应用
KR102500799B1 (ko) 2018-03-09 2023-02-20 삼성디스플레이 주식회사 트랜지스터 기판 및 이를 구비하는 표시 장치
RU2746590C1 (ru) * 2020-10-12 2021-04-16 Федеральное государственное бюджетное образовательное учреждение высшего образования "Вятский государственный университет" Способ эрадикации бактерий Helicobacter pylori при экспериментальном хеликобактериозе у конвенциональных белых мышей и средство для его осуществления

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001083531A1 (en) * 2000-04-27 2001-11-08 MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. Method for identifying helicobacter antigens

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8308235D0 (en) 1983-03-25 1983-05-05 Celltech Ltd Polypeptides
US5225539A (en) 1986-03-27 1993-07-06 Medical Research Council Recombinant altered antibodies and methods of making altered antibodies
US5530101A (en) 1988-12-28 1996-06-25 Protein Design Labs, Inc. Humanized immunoglobulins
US5643578A (en) 1992-03-23 1997-07-01 University Of Massachusetts Medical Center Immunization by inoculation of DNA transcription unit
EP1170368B1 (en) 1994-01-27 2010-07-28 University Of Massachusetts Medical Center Immunization by inoculation of dna transcription unit
US5939400A (en) 1996-02-26 1999-08-17 The Board Of Trustees Of The Leland Stanford Junior University DNA vaccination for induction of suppressive T cell response
US6110898A (en) 1996-05-24 2000-08-29 University Of Maryland, Baltimore DNA vaccines for eliciting a mucosal immune response
EP0977864A2 (en) * 1997-04-25 2000-02-09 Genelabs Technologies, Inc. Antigenic composition and method of detection for helicobacter pylori
IT1298087B1 (it) 1998-01-08 1999-12-20 Fiderm S R L Dispositivo per il controllo della profondita' di penetrazione di un ago, in particolare applicabile ad una siringa per iniezioni
GB9808720D0 (en) * 1998-04-23 1998-06-24 Smithkline Beecham Biolog Novel compounds
US6585975B1 (en) * 1998-04-30 2003-07-01 Acambis, Inc. Use of Salmonella vectors for vaccination against helicobacter infection
AUPP684998A0 (en) * 1998-10-30 1998-11-26 Murdoch Institute for Research into Birth Defects Limited, The A method of recombination and agents useful for same
US6319224B1 (en) 1999-08-20 2001-11-20 Bioject Medical Technologies Inc. Intradermal injection system for injecting DNA-based injectables into humans
US6494865B1 (en) 1999-10-14 2002-12-17 Becton Dickinson And Company Intradermal delivery device including a needle assembly
US7015033B1 (en) * 2000-05-25 2006-03-21 Aventis Pasteur Limited Co-expression of recombination proteins
GB0103170D0 (en) 2001-02-08 2001-03-28 Smithkline Beecham Biolog Vaccine composition
FR2815544B1 (fr) 2000-10-23 2003-02-14 Poudres & Explosifs Ste Nale Seringue sans aiguille securisee a architecture compacte
AT410798B (de) * 2001-01-26 2003-07-25 Cistem Biotechnologies Gmbh Verfahren zur identifizierung, isolierung und herstellung von antigenen gegen ein spezifisches pathogen
EP1622933A2 (en) * 2003-04-22 2006-02-08 Intercell AG H. pylori antigens
WO2007087576A2 (en) * 2006-01-24 2007-08-02 The Uab Research Foundation Compositions and methods for the identification and treatment of immune-mediated inflammatory diseases
EP2004678A1 (en) * 2006-03-15 2008-12-24 Csir Modulation of glutamine synthetase activity
WO2009026615A1 (en) * 2007-08-24 2009-03-05 University Of Wollongong Group a streptococcus pharmaceutical compositions and methods thereof
WO2010068413A1 (en) * 2008-11-25 2010-06-17 Emergent Product Development Gaithersburg Inc. Chlamydia vaccine comprising htra polypeptides

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001083531A1 (en) * 2000-04-27 2001-11-08 MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. Method for identifying helicobacter antigens

Non-Patent Citations (6)

* Cited by examiner, † Cited by third party
Title
GenBank: DAA34967.1*
GenBank: EJC07480.1*
GenBank: EJC09766.1*
GenBank: EJC10337.1*
GenBank: EJC13564.1*
GenBank: EJC53274.1*

Also Published As

Publication number Publication date
RU2017100658A3 (enExample) 2019-02-19
KR20170016989A (ko) 2017-02-14
JP2017521490A (ja) 2017-08-03
CN106573038A (zh) 2017-04-19
AU2015283805A1 (en) 2017-01-05
US11819546B2 (en) 2023-11-21
US20220193216A1 (en) 2022-06-23
JP6634444B2 (ja) 2020-01-22
US20200108135A1 (en) 2020-04-09
EP3160492A4 (en) 2018-01-03
BR112016030728A2 (pt) 2018-02-20
AU2015283805B2 (en) 2021-02-25
WO2016000022A1 (en) 2016-01-07
CN113694191A (zh) 2021-11-26
EP3160492A1 (en) 2017-05-03
RU2017100658A (ru) 2018-07-30
US20170165347A1 (en) 2017-06-15

Similar Documents

Publication Publication Date Title
US11819546B2 (en) Helicobacter therapeutic
TWI681972B (zh) 抗免疫原性醣肽之抗體，包含彼等之組合物及其用途
KR101661946B1 (ko) 스타필로코커스 폐 질환 및 상태에 대한 면역화와 관련된 방법 및 조성물
JP6359492B2 (ja) 抗ＩＬ−１α抗体による癌の処置方法
TWI861227B (zh) 抗α-溶血素的抗體及其應用
CN104968797A (zh) 金黄色葡萄球菌表面决定簇的抗体
CN107073095A (zh) 基于脂多糖缺失的细胞组分的抗鲍氏不动杆菌疫苗
AU2013203774A1 (en) Compositions and methods for immunization against bacteria expressing a carbapenemase
CN112513088A (zh) 抗ox40抗体、其抗原结合片段及其医药用途
JP2021529828A (ja) 炎症性腸疾患を治療するための組成物及び方法
CA2805361A1 (en) Combination of an agonistic anti-cd40 monoclonal antibody or a cd40 ligand and inactivated or attenuated bacteria for use in the treatment and/or prevention of mastitis
CN115151559A (zh) 葡萄球菌肽和使用方法
CN101357942B (zh) 一种中和肠出血性大肠杆菌0157：H7志贺毒素Ⅱ的单克隆抗体、Fab抗体与应用
JP2022517865A (ja) Ｃｘｃｌ１機能に関与する疾患の治療のための組成物および方法
WO2009144240A1 (en) Composition and method for the assay and treatment of anthrax
US9944684B2 (en) CETP antigenic peptide and fusion protein and their composition and applications
Ozberk Design and evaluation of novel liposome-based peptide vaccines for improved efficacy against group A streptococcal infections of the mucosa and skin
HK1238144B (zh) A群链球菌疫苗

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20170124

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application
A201 Request for examination
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 20200629

Comment text: Request for Examination of Application

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20220527

Patent event code: PE09021S01D

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

Patent event code: PE07011S01D

Comment text: Decision to Grant Registration

Patent event date: 20221102

GRNT Written decision to grant
PR0701 Registration of establishment

Comment text: Registration of Establishment

Patent event date: 20221221

Patent event code: PR07011E01D

PR1002 Payment of registration fee

Payment date: 20221222

End annual number: 3

Start annual number: 1

PG1601 Publication of registration